Dr. Shaheed Merani, FRCSC, MD, PhD

Dr. Merani practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Merani's NPI, 1780067579, was assigned on June 30, 2015. Dr. Merani holds Nebraska license 28845.

Dr. Merani's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Merani also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Merani's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Merani is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Merani to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Merani practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Merani's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Merani is licensed in Nebraska.

CMS data shows 308 Medicare services from Dr. Merani across 4 procedure codes in 2024, for 123 Medicare patients. Medicare paid $19,295 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Dr. Merani in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 16% are also on Medicaid. Their average risk score is 3.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Merani's median patient age at 64, with 47% women.

In 2024, Dr. Merani wrote 53 Medicare Part D claims for 14 patients. 70% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $209 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

Dr. Merani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Merani as offering telehealth.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Merani, published from 2011 to 2025. 2019 was the busiest year, with 5. The most frequent topics are Liver Transplantation, Organ Preservation and Tissue and Organ Procurement. Dr. Merani has published most often in Am J Transplant. Dr. Merani's most frequent co-authors are Alan N. Langnas, DO, Wendy J. Grant, MD and Alexander Todd Maskin, MD.

Dmand AI links Dr. Merani to 3 clinical trials. Conditions studied include End Stage Liver Disease and Liver Failure. TransMedics sponsors the most, 2.

CMS Open Payments shows 36 general payments to Dr. Merani from 14 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 68% of the total. TransMedics, Inc. paid the most, $5,802. It also lists 2 research payments totaling $1,432 in 2019.